- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Virax Biolabs Group Ltd (VRAX)
Virax Biolabs Group Ltd stock price live, this page displays NASDAQ VRAX stock exchange data. View the VRAX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Virax Biolabs Group Ltd real time stock price chart below.
What Is the Virax Biolabs Group Ltd Stock Price Today?
The Virax Biolabs Group Ltd stock price today is 1.0300.
What Is the Stock Symbol for Virax Biolabs Group Ltd?
The stock symbol for Virax Biolabs Group Ltd is ""VRAX.""
What Stock Exchange Does Virax Biolabs Group Ltd Trade On?
Virax Biolabs Group Ltd is listed and trades on the NASDAQ stock exchange.
Is Virax Biolabs Group Ltd a Good Stock to Buy?
Determining whether Virax Biolabs Group Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VRAX quote. (ISIN: KYG9495L1251)
What Is the Virax Biolabs Group Ltd Stock Price Today?
The Virax Biolabs Group Ltd stock price today is 1.0300.
What Is the Stock Symbol for Virax Biolabs Group Ltd?
The stock symbol for Virax Biolabs Group Ltd is ""VRAX.""
What Stock Exchange Does Virax Biolabs Group Ltd Trade On?
Virax Biolabs Group Ltd is listed and trades on the NASDAQ stock exchange.
Is Virax Biolabs Group Ltd a Good Stock to Buy?
Determining whether Virax Biolabs Group Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VRAX quote. (ISIN: KYG9495L1251)
NASDAQ
Currency in USD
1.0300
+0.0200(+1.98%)
Closed·
After Hours
1.0298-0.0002(-0.02%)
·
Fair Value
An estimate of a Virax Biolabs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.9900
1.1000
52 wk Range
0.7387
8.9999
VRAX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
An estimate of a Virax Biolabs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.99001.1000
52 wk Range
0.73878.9999
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VRAX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Virax Biolabs's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
3.0000
Upside
+191.26%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy
Virax Biolabs Group Ltd Company Profile
Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women’s health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary diagnostics under the ViraxVet brand. It also provides ViraxImmune, a T cell In vitro diagnostic device and wellness mobile application; and service, such as antibody engineering, custom peptides, protein sequencing, vaccine efficacy testing, immunology lab services, kits and reagents. In addition, the company is involved in research and development activities; and provision of procurement, warehousing, product development, and staffing management services. It serves research organizations, corporations, independent laboratories, large hospital systems and public and private institutions, as well as distributor customers. The company operates in the United Kingdom, the United States, and China. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was founded in 2013 and is headquartered in Lanarkshire, the United Kingdom.
Compare VRAX to Peers and Sector
Metrics to compare | VRAX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVRAXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.7x | −0.2x | −0.5x | |
PEG Ratio | −0.01 | 0.01 | 0.00 | |
Price/Book | 0.8x | 1.1x | 2.6x | |
Price / LTM Sales | 682.7x | 1.1x | 3.2x | |
Upside (Analyst Target) | 201.4% | 41.9% | 41.9% | |
Fair Value Upside | Unlock | 21.4% | 4.3% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3.0000
(+191.26% Upside)
Earnings
Latest Release
Jul 02, 2025
EPS / Forecast
-0.76 / --
Revenue / Forecast
1.38K / --
People Also Watch
FAQ
What Stock Exchange Does Virax Biolabs Trade On?
Virax Biolabs is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Virax Biolabs?
The stock symbol for Virax Biolabs is "VRAX."
What Is the Virax Biolabs Market Cap?
As of today, Virax Biolabs market cap is 4.32M.
What Is Virax Biolabs's Earnings Per Share (TTM)?
The Virax Biolabs EPS (TTM) is -1.62.
From a Technical Analysis Perspective, Is VRAX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Virax Biolabs Stock Split?
Virax Biolabs has split 1 times.
How Many Employees Does Virax Biolabs Have?
Virax Biolabs has 19 employees.
What is the current trading status of Virax Biolabs (VRAX)?
As of 24 Jul 2025, Virax Biolabs (VRAX) is trading at a price of 1.03, with a previous close of 1.00. The stock has fluctuated within a day range of 0.99 to 1.10, while its 52-week range spans from 0.74 to 9.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.